Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Huntersville NC
Sponsor: Nanjing Zenshine Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05118841

Phase 1, Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

for
Diabetes Mellitus, Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03415139

Recruiting

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

for
Advanced Solid Tumors
Location: Orange City FL, Lake City FL, Houston TX
Sponsor: Abion Inc

Sex: All

Age: 18+

Code: NCT05541822

Phase 2, Recruiting

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

for
Symptoms and Signs, Cancer, Childhood Cancer
Location: Richmond VA, Kansas City MO, Salt Lake City UT
Sponsor: Virginia Commonwealth University

Sex: All

Age: 15 - 29

Code: NCT05958316

Recruiting

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

for
Cancer, Thoracic Cancer, Gynecologic Cancer,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06633224

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, Plantation FL, Tamarac FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05785741

Phase 1, Phase 2, Recruiting

FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations

for
Solid Tumor, MET Alteration
Location: Washington D.C. DC, Canton OH, Nashville TN
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06669117

Phase 1, Phase 2, Recruiting

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor
Location: Denver CO, San Antonio TX, Duarte CA, LA CA,
Sponsor: ABL Bio, Inc.

Sex: All

Age: 18+

Code: NCT04762641

Phase 1, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: New York NY, Fairfax VA, Margate FL, Plantation FL,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase 1, Phase 2, Recruiting

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02464696

Recruiting

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

for
Cancer, Cancer Pain, Virtual Reality
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT06248216

Recruiting

Cancer and Mild Cognitive Impairment Dyadic Intervention

for
Cancer, Cognitive Impairment
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 70+

Code: NCT05144516

Recruiting

Communication Issues in Patient and Provider Discussions of Immunotherapy

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Decatur GA, Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT05873608

Recruiting

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

for
Metastatic Cancer
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06389123

Phase 1, Recruiting

Weighted Blanket Use to Reduce Anxiety in Oncology Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06089408

Recruiting

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

for
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer,
Location: Philadelphia PA, Memphis TN, Houston TX, Seattle WA,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 2 - 70+

Code: NCT05783323

Phase 2, Recruiting

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05411523

Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase 1, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase 1, Phase 2, Recruiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

for
Neoplasms, Chemotherapy-induced Nausea and Vomiting
Location: Miami FL, Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 60+

Code: NCT05838638

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial